Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy

Loftus, Edward VEdward VLoftusDavis, Keith LKeith LDavisCHI-CHUAN WANGDastani, HomaHomaDastaniLuo, AllisonAllisonLuo2024-03-282024-03-282014-0810780998https://scholars.lib.ntu.edu.tw/handle/123456789/641540Immunomodulator (IM) treatments in ulcerative colitis (UC) are not curative and carry increased risk of complications, sometimes leading to therapy changes, reduced treatment benefits, and eventual relapse. We assessed patterns of IM utilization and therapy changes, complications, and disease relapse in a real-world population of patients with moderate-to-severe UC.enComplications | Immunomodulators | Relapse | Treatment patterns | Ulcerative colitisTreatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapyjournal article10.1097/MIB.0000000000000089249183202-s2.0-84905496700https://api.elsevier.com/content/abstract/scopus_id/84905496700